Research and Markets : For the Eighth Year Running, Flomox is Shionogi's Largest Selling Drug.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48331) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Shionogi: Prospects to 2010 to their offering. Shionogi operates in around ten business fields, and principal among these is its Pharmaceuticals segment. Within this business segment, Shionogi is active in the following therapeutic areas: Antibiotics, Central Nervous System, Circulatory circulatory /cir·cu·la·to·ry/ (ser´ku-lah-tor?e) 1. pertaining to circulation, particularly that of the blood. 2. containing blood. cir·cu·la·to·ry n. 1. and Respiratory System respiratory system: see respiration. respiratory system Organ system involved in respiration. In humans, the diaphragm and, to a lesser extent, the muscles between the ribs generate a pumping action, moving air in and out of the lungs through a , and Anticancer. As part of Shionogi's Second Medium-Term Management Plan (which began in April 2005, and runs until fiscal 2010), the company is planning to focus research efforts specifically in the treatment of infections, pain and metabolic syndrome metabolic syndrome n. See syndrome X. Metabolic syndrome A group of risk factors for heart disease, diabetes, and stroke. . Current Growth Drivers For the eighth year running, Flomox is Shionogi's largest selling drug, and is the company's core product supporting Shionogi's leadership in the domestic antibiotic market. Although sales have been in decline, Shionogi have insisted they will continue to invest in this product, maximising its value Shionogi licensed-in exclusive Japanese marketing rights to the oral quinolone antibiotic, Avelox, from Bayer Yakuhin in October 2005. Avelox was launched in Japan in December 2005, and will become a core Anti-infective product. Sales of Claritin, an anti-allergic agent, have risen strongly due to increased market awareness and a domestic increase in pollen allergies. The launch of the new Claritin RediTab formulation helped further boost sales, whilst a new orphan indication was filed in September 2004. Shionogi only retain data exclusivity for the drug until March 2009, after which sales are anticipated to fall rapidly. OxyContin Ox·y·con·tin A trademark for the drug oxycodone. oxycodone hydrochloride ETH-Oxydose, OxyContin, OxyFast, Oxy-IR, Oxynorm (UK), Roxicodone, Supeudol (CA) Pharmacologic class: Opioid agonist , a controlled released oral analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs , is set to be the foundation for Shionogi's future core therapeutic area for the treatment of pain. Products Mentioned Include: Flomox Avelox Claritin OxyContin Summary Pharmaceutical company intelligence reports provide a full review of the companys activities together with five-year sales forecasts for its key products. The companys financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the companys product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events. Companies Mentioned * AstraZeneca * Bayer * Bristol-Myers Squibb/sanofi-aventis * Eli Lilly Eli Lilly can refer to:
* Enanta Pharmaceuticals Inc * Galderma KK * GlaxoSmithKline * Kyowa Hakko Kogyo Ltd * Marnac Inc/KDL Inc * Peninsula Pharmaceuticals Inc * MundiPharma BV * Purdue Pharma Purdue Pharma L.P., is privately-held pharmaceutical company founded by physicians. It is located in Stamford, Connecticut. Purdue is best known for painkillers, but they have also branched into other areas such as oncology and nutraceuticals. LP * Response Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Corporation * Roche * Schering-Plough * Pfizer For more information visit http://www.researchandmarkets.com/reports/c48331 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion